- Editorial
3,780 Views
2 Pages
In this issue of Biologics, we publish an article describing a surprising clinical effect of the anti-helminthic drug ivermectin on patients with COVID-19 [...]
- 7.2CiteScore
- 24 daysTime to First Decision
Biologics, Volume 2, Issue 3
September 2022 - 4 articles
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles (4)
- Article
8 Citations
22,590 Views
15 Pages
Changes in SpO2 on Room Air for 34 Severe COVID-19 Patients after Ivermectin-Based Combination Treatment: 62% Normalization within 24 Hours
- Jaqueline C. Stone,
- Pisirai Ndarukwa,
- David E. Scheim,
- Barry M. Dancis,
- Jerome Dancis,
- Martin G. Gill and
- Colleen Aldous
The emergence of COVID-19 in March 2020 challenged Zimbabwe to respond with limited medical facilities and therapeutic options. Based on early clinical indications of efficacy for the macrocyclic lactone, Ivermectin (IVM), against COVID-19, IVM-based...
- Review
23 Citations
11,982 Views
25 Pages
Biosimilars: Harmonizing the Approval Guidelines
- Sarfaraz K. Niazi
Biosimilar approval guidelines need rationalization and harmonization to remove the inconsistencies and misconceptions to enable faster, safer, and more cost-effective biosimilars. This paper proposes a platform for a model guideline based on the sci...
- Editorial
3 Citations
3,686 Views
6 Pages
Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes
- Vivek P. Chavda,
- Mahesh T. Chhabria and
- Vasso Apostolopoulos
Patients with an immunocompromised state are at risk of developing a long-term infection from the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2) [...]
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Biologics - ISSN 2673-8449